Instadose Pharma (Instadose Pharma) LT-Debt-to-Total-Asset : 0.00 (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Instadose Pharma's long-term debt to total assests ratio for the quarter that ended in Feb. 2022 was 0.00.

Instadose Pharma's long-term debt to total assets ratio increased from Feb. 2021 (0.00) to Feb. 2022 (0.00). It may suggest that Instadose Pharma is progressively becoming more dependent on debt to grow their business.

Instadose Pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Instadose Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma LT-Debt-to-Total-Asset Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Instadose Pharma LT-Debt-to-Total-Asset Calculation

Instadose Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Nov. 2021 is calculated as

LT Debt to Total Assets (A: Nov. 2021 )	=	Long-Term Debt & Capital Lease Obligation (A: Nov. 2021 )	/	Total Assets (A: Nov. 2021 )
	=	0	/	0
	=

Instadose Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Feb. 2022 is calculated as

LT Debt to Total Assets (Q: Feb. 2022 )	=	Long-Term Debt & Capital Lease Obligation (Q: Feb. 2022 )	/	Total Assets (Q: Feb. 2022 )
	=	0.065	/	36.142
	=

Instadose Pharma (OTCPK:INSD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Instadose Pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.